The eight key areas biopharma manufacturers must stay on top of when planning and executing alliance agreements with prospective digital health partners.
Emily Lowe, Michele Buenafe, and Kelli Boyle
Advertisement
Emily Lowe, Michele Buenafe, and Kelli Boyle — Morgan, Lewis & Bockius LLP.
Articles by Emily Lowe, Michele Buenafe, and Kelli Boyle
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
2
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
3
FDA Approves Wegovy HD Injectable Under Accelerated Approval
4
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
5